Randomised, Crossover Bioavailability Clinical Trial of Oral Minoxidil 1 MG, After Single and Multiple Dose Administration to Healthy Volunteers Under Fasting Conditions.

This clinical trial is focused on understanding how the body absorbs and processes a new oral form of minoxidil, a medication usually used to treat hair loss. The study specifically targets healthy women between the ages of 18 and 55. By comparing the new oral tablet form of minoxidil to the existing topical solution, the research aims to see how much of the drug actually gets into the bloodstream when taken as a pill. This information could be crucial for developing new treatment methods that may be more effective or convenient for patients. During the study, participants receive either the oral minoxidil tablet or the topical solution in a specific order. Each participant takes the medication once a day for five days, with a break of at least seven days between different treatments to ensure accurate results. The researchers measure how much of the drug is present in the blood at different times to understand how the body absorbs it. The study is designed as a crossover trial, meaning each participant tries both forms of the medication, allowing for a direct comparison of the two methods. The main focus is on determining how effectively the body takes in the oral form compared to the topical solution.